Navigation Links
Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15)
Date:5/9/2008

s compared to

men of normal weight at the time of diagnosis. "If a man is obese

at the time of diagnosis, he faces a 2.6-times greater risk of dying as

compared to a normal-weight man with the same diagnostic profile,

regardless of whether he has a radical prostatectomy or radiation

therapy, whether or not he gets androgen-deprivation therapy, whether he

has low- or high-grade disease or whether he has localized, regional or

distant disease," Kristal said.

-- Heavy smokers who are diagnosed with prostate cancer have twice the risk

of dying from their disease. Smoking may promote prostate cancer growth

through several mechanisms. One is that it can increase the amount of

circulating androgens, which fuels the growth of malignant prostate

cells. Another theory is related to tobacco as a source of cadmium, a

heavy metal that has been linked to prostate cancer in several

occupational-health studies. This known human carcinogen inhibits DNA

repair, which allows cancer cells to mutate and multiply.

-- African-American men are known to have a higher risk of prostate cancer

than white men. Kristal and colleagues also found that African-American

men have a 50 percent higher risk of developing symptomatic BPH than

white men.

-- The excitement about lycopene (the pigment that puts the red in

tomatoes) and prostate-cancer prevention is probably a mistake, Kristal

says. Most large and well-designed human studies, and most animal

studies, have failed to find convincing associations between lycopene

and reduced prostate-cancer risk. Men should be wary of quick fixes like

lycopene supplements, vegetable-juice powders or other agents promoted

for prostate-cancer prevention.

The take-away messag
'/>"/>

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds & Flu
2. Molecular Therapy Succeeds in Preventing Craniofacial Birth Defect in Mice
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
5. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
8. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
9. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
10. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
11. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Outsourcing Opportunities in the Medica...nker.com/p0165747/Outsourcing-Opportunities-in-the..., Medical devices form one of the largest indust...f $250 billion in 2009 and a growth rate of 6%-8%....
(Date:11/30/2009)...Newswire/ -- StemCyte, Inc. concluded an exclusive...emia Sinica, the National Laboratory of Taiwan, fo...perty (IP) related to the treatment of Chronic Str...ered by a team led by Professor John Lin, MD, PhD ...currently the exclusive collaborator with StemCyte...
(Date:11/30/2009)...0 Cytokine PharmaSciences, Inc. to... CPSI-2364, its orally active, small-molecule inhi...-inflammatory cytokines. Results of the safety an...lunteers confirm the safety of this compound in in...bjects completed the study, including those receiv...
Breaking Medicine Technology:Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Surviving Healthcare Reform 3A How Biopharma Companies Can Come Out on Top 60842 1Surviving Healthcare Reform 3A How Biopharma Companies Can Come Out on Top 60842 2Mineral BioSciences to Attend SupplySide West in Las Vegas 60837 1Mineral BioSciences to Attend SupplySide West in Las Vegas 60837 2Poor Restroom Cleaning Causes Cruise Ship Sickness 60833 1Poor Restroom Cleaning Causes Cruise Ship Sickness 60833 2
...of its Kind to Achieve Enrollment Milestone, MENL...,in the development of devices for the percutaneou...mpletion of randomized enrollment in the,Endovascu...ch is evaluating,the MitraClip(R) system as a non-... mitral regurgitation (MR). MR is the most common ...
...ry, Sept. 30 ,Forest Laboratories, Inc. (NYSE: FR...nary top-line results from a phase II clinical tri...tipsychotic, in patients with,acute mania associat...nt,the Young Mania Rating Scale (YMRS), the data s...ted with cariprazine experienced significant,sympt...
Other Medicine Technology:Evalve Announces Enrollment Completion of the EVEREST Randomized Study 2Evalve Announces Enrollment Completion of the EVEREST Randomized Study 3Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 2Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 3Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 4Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 5
(Date:11/30/2009)...of Navarra Hospital has launched a series of clini...mmunotherapy treatment. This approach involves the...m healthy and tumour cells from the patient him or... of the most aggressive and frequent malignant tum...ting patients combined with the standard, first-li...
(Date:11/30/2009)... Author of "My Two-Year Old Eats Octo...n who love to eat everything. , ...picky eater in your house? Do you find yourself a...w short online videos – one focusing on pack...rd on answers for real-life parents’ questio...
(Date:11/30/2009)...at worsens over time, so do knees, internal injuri...ealthDay News) -- If you,re a middle-age weekend w...ckey rink, take note: A new study suggests that hi...nternal knee damage that could lead to osteoarthri...ed in middle-age people who showed no symptoms and...
(Date:11/30/2009)..., SHENZHEN, China, Nov. 30 /PRNewswire-FirstCall/...medical.com/ ) operating subsidiary Mellow Hope fi...anufacturer of intravenous medication in India. Th...es for Hard to Treat Diseases in the following qua...ian company secures the supply of raw pharmaceutic...
(Date:11/30/2009)... Red Cross offers online giving catalog to help fa... ,, WASHINGTON, Nov. 30 /PRNewswire-USNewswir... are entering this holiday season willing to suppo... to dig deep into their own wallets to support cha...bout donating to charity instead of buying them a ...
Breaking Medicine News(10 mins):Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 3Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 3
...17-year old Irish girl who made headlines recently... by asserting her right to abort has got the nod ...the Court demanding that she be allowed to go to B...the foetus she is carrying suffers from anencephal...
...new vaccine aimed at preventing cervical cancer is...s of the human papillomavirus (HPV) responsible f...ionwide study of the vaccine will be published in ...ine marketed by Merck under the name Gardasil coul...
...combination of molecular-targeted therapy and horm...earch for those seeking an effective treatment fo... International Journal of Gynecological Cancer. ...tumors, says review author Dr. Siqing Fu, an assis...
...dia is home to over 76.6 million people over the a...e health ministry, the country has 76,622,321 per...cent of the elderly population, Uttar Pradesh tops... have 5.5 million senior citizens each. De...
... line with Ranbaxy Laboratories aggressive interna... Africa's Competition Commission has solidified th...mited ("Be-Tabs") by Ranbaxy Laboratories. (RNBV).... Ranbaxy Laboratories Limited, headquartered...
...alth authorities in the US are worried about yet a...quito-spread infection. Rudy Bueno, the Chi...id that the situation may worsen if people don't f...ellants or going out at night in short-sleeve shir...
Other Medicine News:Health News:Pregnant Irish Teenager Wins the Right to Abort 2Health News:Study Shows Continued Success for New HPV Vaccine Against Virus 2Health News:Ranbaxy Labs Extends Roots in South Africa 2Health News:Ranbaxy Labs Extends Roots in South Africa 3Health News:Health Authorities Fear West Nile Season Again in US 2
Core Malaria Pv-Pf
NOW® Malaria Test (P. Falciparum)
Ultraview 1700 Central Monitor
...Central Station provide an example of the Witt int...or electrophysiology lab to healthcare professiona...viding both physiomonitoring parameters and electr...on its own network. Witts Central Station can moni...
Medicine Products: